NO329809B1 - Perorale sammensetninger av levosimendan med kontrollert frigjoring - Google Patents

Perorale sammensetninger av levosimendan med kontrollert frigjoring Download PDF

Info

Publication number
NO329809B1
NO329809B1 NO20005313A NO20005313A NO329809B1 NO 329809 B1 NO329809 B1 NO 329809B1 NO 20005313 A NO20005313 A NO 20005313A NO 20005313 A NO20005313 A NO 20005313A NO 329809 B1 NO329809 B1 NO 329809B1
Authority
NO
Norway
Prior art keywords
levosimendan
composition
release
drug
controlled release
Prior art date
Application number
NO20005313A
Other languages
English (en)
Norwegian (no)
Other versions
NO20005313L (no
NO20005313D0 (no
Inventor
Saila Antila
Lasse Lehtonen
Maarit Backman
Ilkka Larma
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8551575&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO329809(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Orion Corp filed Critical Orion Corp
Publication of NO20005313D0 publication Critical patent/NO20005313D0/no
Publication of NO20005313L publication Critical patent/NO20005313L/no
Publication of NO329809B1 publication Critical patent/NO329809B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Detergent Compositions (AREA)
  • Cosmetics (AREA)
NO20005313A 1998-04-23 2000-10-20 Perorale sammensetninger av levosimendan med kontrollert frigjoring NO329809B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI980901A FI980901A7 (fi) 1998-04-23 1998-04-23 Levosimendaania säädellysti vapauttavia oraalisia koostumuksia
PCT/FI1999/000329 WO1999055305A2 (en) 1998-04-23 1999-04-23 Controlled release peroral compositions of levosimendan

Publications (3)

Publication Number Publication Date
NO20005313D0 NO20005313D0 (no) 2000-10-20
NO20005313L NO20005313L (no) 2000-11-21
NO329809B1 true NO329809B1 (no) 2010-12-20

Family

ID=8551575

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005313A NO329809B1 (no) 1998-04-23 2000-10-20 Perorale sammensetninger av levosimendan med kontrollert frigjoring

Country Status (37)

Country Link
US (1) US7045147B1 (cs)
EP (1) EP1071397B1 (cs)
JP (2) JP4566402B2 (cs)
KR (1) KR100960597B1 (cs)
CN (1) CN1248691C (cs)
AR (1) AR019096A1 (cs)
AT (1) ATE258425T1 (cs)
AU (1) AU756641B2 (cs)
BG (1) BG64839B1 (cs)
BR (1) BR9909869A (cs)
CA (1) CA2329234C (cs)
CO (1) CO5070607A1 (cs)
CZ (1) CZ295194B6 (cs)
DE (1) DE69914472T2 (cs)
DK (1) DK1071397T3 (cs)
EA (1) EA002829B1 (cs)
EE (1) EE04220B1 (cs)
ES (1) ES2215379T3 (cs)
FI (1) FI980901A7 (cs)
GE (1) GEP20032906B (cs)
HR (1) HRP20000704B1 (cs)
HU (1) HUP0101458A3 (cs)
ID (1) ID27987A (cs)
IL (2) IL138951A0 (cs)
MX (1) MXPA00010367A (cs)
NO (1) NO329809B1 (cs)
NZ (1) NZ507453A (cs)
PL (1) PL197447B1 (cs)
PT (1) PT1071397E (cs)
RS (1) RS49962B (cs)
SI (1) SI1071397T1 (cs)
SK (1) SK285427B6 (cs)
TR (1) TR200003102T2 (cs)
TW (1) TWI224507B (cs)
UA (1) UA68376C2 (cs)
WO (1) WO1999055305A2 (cs)
ZA (1) ZA200005632B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20011465A0 (fi) * 2001-07-04 2001-07-04 Orion Corp Pyridatsinonijohdannaisen uusi käyttö
MXPA05009886A (es) * 2003-03-14 2006-05-04 Nirmal Mulye Un proceso para preparar tabletas de liberacion constante.
FI20070521A7 (fi) * 2006-11-10 2008-05-11 Atacama Labs Oy Rakeita, tabletteja ja rakeistusmenetelmä
BRPI0915284B1 (pt) 2008-06-30 2020-01-14 Tocagen Inc composição farmacêutica oral, e, uso de uma composição farmacêutica
JP2014172850A (ja) * 2013-03-07 2014-09-22 Capsugel Belgium Nv ハードカプセル製剤
CN105784895B (zh) * 2015-10-30 2018-05-22 成都欣捷高新技术开发有限公司 一种用高效液相色谱仪检测左西孟旦中杂质的方法
AU2020408323A1 (en) 2019-12-16 2022-08-11 Tenax Therapeutics, Inc. Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HF-pEF)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU555304B2 (en) 1982-04-05 1986-09-18 Merck Sharp & Dohme Limited Stabilization of drugs in alginic acid and magnesium hydroxide granules
US4716042A (en) 1986-06-16 1987-12-29 American Home Products Corporation Stabilized coated aspirin tablets
GB8903130D0 (en) 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
US5213811A (en) * 1991-09-13 1993-05-25 Sterling Drug Inc. Oral sustained-release drug compositions
GB2266841A (en) * 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
US5795909A (en) * 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
GB9614098D0 (en) * 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan
FI973804A7 (fi) * 1997-09-26 1999-03-27 Orion Yhtymae Oy Levosimendaanin oraalisia koostumuksia
FI974578L (fi) * 1997-12-19 1999-06-20 Orion Yhtymae Oyj Menetelmä levosimendaanin antamiseksi
FI980902A7 (fi) * 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaanin stabiileja koostumuksia

Also Published As

Publication number Publication date
CA2329234A1 (en) 1999-11-04
YU63900A (sh) 2003-07-07
DE69914472T2 (de) 2004-11-11
FI980901A0 (fi) 1998-04-23
PL344078A1 (en) 2001-09-24
TWI224507B (en) 2004-12-01
US7045147B1 (en) 2006-05-16
HRP20000704A2 (en) 2001-04-30
WO1999055305A3 (en) 1999-12-29
ATE258425T1 (de) 2004-02-15
ID27987A (id) 2001-05-03
EE200000617A (et) 2002-06-17
CO5070607A1 (es) 2001-08-28
DK1071397T3 (da) 2004-04-05
PL197447B1 (pl) 2008-03-31
NO20005313L (no) 2000-11-21
JP4566402B2 (ja) 2010-10-20
MXPA00010367A (es) 2002-06-04
ZA200005632B (en) 2002-01-14
EA200001098A1 (ru) 2001-04-23
AR019096A1 (es) 2001-12-26
KR20010071172A (ko) 2001-07-28
EP1071397B1 (en) 2004-01-28
ES2215379T3 (es) 2004-10-01
NO20005313D0 (no) 2000-10-20
CZ20003780A3 (en) 2001-05-16
FI980901A7 (fi) 1999-10-24
EA002829B1 (ru) 2002-10-31
BG64839B1 (bg) 2006-06-30
EP1071397A2 (en) 2001-01-31
CN1301163A (zh) 2001-06-27
HK1034032A1 (en) 2001-10-12
EE04220B1 (et) 2004-02-16
DE69914472D1 (de) 2004-03-04
SI1071397T1 (en) 2004-06-30
BG104959A (en) 2001-07-31
AU3524699A (en) 1999-11-16
CZ295194B6 (cs) 2005-06-15
SK15542000A3 (sk) 2001-08-06
HUP0101458A3 (en) 2002-05-28
AU756641B2 (en) 2003-01-16
JP2002512946A (ja) 2002-05-08
TR200003102T2 (tr) 2001-02-21
WO1999055305A2 (en) 1999-11-04
CA2329234C (en) 2008-06-10
IL138951A (en) 2006-10-31
UA68376C2 (en) 2004-08-16
BR9909869A (pt) 2000-12-19
KR100960597B1 (ko) 2010-06-07
PT1071397E (pt) 2004-06-30
IL138951A0 (en) 2001-11-25
HRP20000704B1 (hr) 2009-11-30
SK285427B6 (sk) 2007-01-04
JP2010083900A (ja) 2010-04-15
HUP0101458A2 (hu) 2002-03-28
GEP20032906B (en) 2003-02-25
CN1248691C (zh) 2006-04-05
NZ507453A (en) 2003-02-28
RS49962B (sr) 2008-09-29

Similar Documents

Publication Publication Date Title
US20210093575A1 (en) Immediate release formulations and dosage forms of gamma-hydroxybutyrate
AU2010352575B2 (en) Immediate release formulations and dosage forms of gamma-hydroxybutyrate
KR100712032B1 (ko) 신규한 페노피브레이트 갈레노스 제제의 제조방법, 제조된갈레노스 제제 및 용도
AT9978U1 (de) Tamsulosin-hältige matrixtablette
NO330260B1 (no) Oral, fast sammensetning omfattende levodopa/carbidopa/entacapon, fremgangsmate for fremstilling derav, samt anvendelse av en sammensetning omfattende levodopa/carbidopa/entacapon for fremstilling av et medikament til behandling av Parkinsons sykdom.
KR20150028367A (ko) 히드로모르폰 및 날록손을 포함하는 제약 조성물
JP2010083900A (ja) レボシメンダンの制御放出経口用組成物
CN110913843B (zh) 药物组合物
HK1034032B (en) Controlled release peroral compositions of levosimendan
HK1182964B (en) Immediate release formulations and dosage forms of gamma-hydroxybutyrate
HK1182964A (en) Immediate release formulations and dosage forms of gamma-hydroxybutyrate

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees